Search Results 501-510 of 17398 for alopecia

  1. A Study to Evaluate M7824 with Concurrent Chemoradiation (cCRT) in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

    Participants with diabetes Type I, vitiligo, alopecia, psoriasis, hypo- or hyperthyroid disease not requiring immunosuppressive treatment are eligible.

  2. Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Any unresolved toxicity NCI CTCAE Grade ≥2 from previous anticancer therapy with the exception of alopecia, vitiligo, and the laboratory values defined in the ...

  3. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  4. Mayo Clinic

    Share · Tweet . IMG-20420243. Home; Giving to Mayo Clinic-Ways to Give-Employee and Retiree Giving. 5X Challenge is here!

  5. Lice - Symptoms and causes - Mayo Clinic

    Lice are tiny, wingless insects that feed on human blood. Lice spread from person to person through close contact and by sharing clothes and other items.

  6. Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL - Mayo Clinic

    ... alopecia) due to therapy administered prior to the initiation of study drug dosing. Nursing or pregnant. Known allergy or hypersensitivity to any of the ...

  7. Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma - Mayo Clinic

    Any unresolved toxicity NCI CTCAE Grade ≥ 2 from previous anticancer therapy; with the exception of vitiligo and alopecia. Participating Mayo Clinic ...

  8. Brightcove-Stereotactic radiosurgery-the mayo clinic approach

    Bruce Pollock, M.D., Neurosurgery, Mayo Clinic: Stereotactic radiosurgery is an outpatient-based radiation procedure. You're going to walk in, have this done, ...

  9. A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

    ... alopecia or peripheral neuropathy. Have discontinued all previous therapies for cancer (including chemotherapy, radiotherapy, immunotherapy, and endocrine ...

  10. A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer - Mayo Clinic

    ... alopecia (any grade permissible). No more than one prior chemotherapy regimen for advanced or metastatic breast cancer is allowed; prior chemotherapy for ...